Prognostic significance of HER2/neu expression in gastric cancer

Wiener Klinische Wochenschrift

Volumn 123, Issue 13-14, 2011, Pages 450-454

  Ananiev, Julian ^a   Gulubova, Maya ^a   Manolova, Irena ^b   Tchernev, Georgi ^a  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b University Hospital   (Bulgaria)

Author keywords

Gastric cancer; HER2 neu membrane staining; Immunohistochemistry

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PATHOLOGY; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, ERBB-2; STOMACH; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80052551119     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-011-0025-9     Document Type: Article

References (33)

1. DC Farrow TL Vaughan 1996 Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States) Cancer Causes Control 7 3 322 327 8734825 10.1007/BF00052937 1:STN:280:DyaK28zhslShtw%3D%3D (Pubitemid 26163884)
2. G Gravalos A Jimeno 2008 HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target Ann Oncol 19 9 1523 1529 18441328 10.1093/annonc/mdn169 1:STN:280:DC%2BD1crivFajtQ%3D%3D
3. J Schlessinger 2000 Cell signaling by receptor tyrosine kinases Cell 103 2 211 225 11057895 10.1016/S0092-8674(00)00114-8 1:CAS:528:DC%2BD3cXns1Cltrs%3D
4. Y Yarden MX Sliwkowski 2001 Untangling the ErbB signalling network Nat Rev Mol Cell Biol 2 2 127 137 11252954 10.1038/35052073 1:CAS:528: DC%2BD3MXivVWnt7k%3D (Pubitemid 33674041)
5. NE Hynes K Horsch MA Olayioye, et al. 2001 The ErbB receptor tyrosine family as signal integrators Endocr Relat Cancer 8 151 159 11566606 10.1677/erc.0.0080151 1:CAS:528:DC%2BD3MXotlCqsLw%3D (Pubitemid 32947637)
6. I Rubin Y Yarden 2001 The basic biology of HER2 Ann Oncol 12 1 S3 S8 11521719 10.1023/A:1011195320446 (Pubitemid 32750577)
7. DJ Slamon W Godolphin LA Jones, et al. 1989 Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 707 712 2470152 10.1126/science.2470152 1:STN:280:DyaL1M3kt1Wntg%3D%3D (Pubitemid 19147683)
8. SJ McKenzie KA DeSombre BS Bast, et al. 1993 Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer Cancer 71 3942 3946 8099528 10.1002/1097-0142(19930615)71:12<3942::AID- CNCR2820711224>3.0.CO;2-3 1:STN:280:DyaK3s3osVGjuw%3D%3D (Pubitemid 23172974)
9. SD Xie CY Xu JG Shen, et al. 2009 HER 2/neu protein expression in gastric cancer is associated with poor survival Molecular Medicine REPORTS 2 943 946 21475925 10.3892/mmr-00000180 1:CAS:528:DC%2BD1MXht12qsrzF
10. JA Cohen DB Weiner KF More, et al. 1989 Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract Oncogene 4 81 88 2563577 1:CAS:528:DyaK3cXmtV2is70%3D (Pubitemid 19085073)
11. K Sakai S Mori T Kawamoto, et al. 1986 Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas J Natl Cancer Inst 77 1047 1052 3464796 1:CAS:528:DyaL28Xmt1ektbw%3D (Pubitemid 17184126)
12. A Webb P Scott-Mackie D Cunningham, et al. 1996 The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer Eur J Cancer 32A 63 68 8695243 10.1016/0959-8049(95)00504-8 1:STN:280: DyaK283ks1Sjsw%3D%3D
13. H Orita Y Maehara Y Emi, et al. 1997 c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma Hepatogastroenterology 44 294 298 9058162 1:STN:280:DyaK2s3htFWltg%3D%3D (Pubitemid 27096056)
14. S Uchino H Tsuda K Maruyama, et al. 1993 Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients Cancer 72 3179 3184 7902202 10.1002/1097-0142(19931201)72:11<3179::AID- CNCR2820721108>3.0.CO;2-# 1:STN:280:DyaK2c%2FmtFOntA%3D%3D (Pubitemid 23356757)
15. S Chariyalertsak K Sugano H Ohkura, et al. 1994 Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer Tumour Biol 15 294 303 7991990 10.1159/000217904 1:STN:280: DyaK2M%2FosVSruw%3D%3D (Pubitemid 24360699)
16. P Kolodziejczyk T Yao M Oya, et al. 1994 Long-term follow-up study of patients with gastric adenomas with malignant transformation. An immunohistochemical and histochemical analysis Cancer 74 2896 2907 7954254 10.1002/1097-0142(19941201)74:11<2896::AID-CNCR2820741103>3.0.CO;2-P 1:STN:280:DyaK2M%2Fkt1Wnsw%3D%3D (Pubitemid 24361073)
17. M Tateishi T Toda Y Minamisono, et al. 1992 Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma J Surg Oncol 49 209 212 1348293 10.1002/jso.2930490402 1:STN:280:DyaK383htF2mug%3D%3D
18. Sobin LH, Wittekind Ch. TNM Classification of Malignant Tumours 6th ed. (eds) Wiley-Liss: New York. 2002;65-9
19. P Lauren 1965 The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 31 49 14320675 1:STN:280:DyaF2M7isFenug%3D%3D
20. JS Chen K Lan MC Hung 2003 Strategies to target HER2/neu overexpression for cancer therapy Drug Resist Updat 6 3 129 136 12860460 10.1016/S1368-7646(03) 00040-2 1:CAS:528:DC%2BD3sXlsVSmt7c%3D (Pubitemid 36890337)
21. M Hofmann O Stoss D Shi, et al. 2008 Assessment of a HER2 scoring system for gastric cancer: results from a validation study Histopathology 52 7 797 805 18422971 10.1111/j.1365-2559.2008.03028.x 1:STN:280:DC%2BD1czjtFWlsA%3D%3D (Pubitemid 351724903)
22. L Coussens TL Yang-Feng YC Liao, et al. 1985 Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene Science 230 1132 1139 2999974 10.1126/science.2999974 1:CAS:528:DyaL28XmslKhuw%3D%3D (Pubitemid 16169997)
23. N Kiyokawa D Karunagaran EK Lee, et al. 1997 Involvement of cdc2-mediated phosphorylation in the cell cycle-dependent regulation of p185neu Oncogene 15 2633 2641 9400990 10.1038/sj.onc.1201442 1:CAS:528:DyaK2sXotVWns7c%3D (Pubitemid 27507611)
24. H Allgayer R Babic KU Gruetzner, et al. 2000 C-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor associated protease systems J Clin Oncol 18 2201 2209 10829039 1:STN:280:DC%2BD3c3ptFajtw%3D%3D (Pubitemid 30350211)
25. SC Wang MC Hung 2001 HER2 overexpression and cancer targeting Semin Oncol 28 115 124 11706403 10.1016/S0093-7754(01)90289-1 1:CAS:528: DC%2BD3MXpt1Wnsr0%3D
26. J Matsubara Y Hirashima 2008 Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER 2 expression on outcomes of patients with gastric cancer Clin Res 14 3022 3029 10.1158/1078-0432.CCR-07-1898 1:CAS:528:DC%2BD1cXmtVCmtLc%3D
27. DA Hilton KP West 1992 c-erbB-2 oncogene product expression and prognosis in gastric carcinoma J Clin Pathol 45 454 456 1350789 10.1136/jcp.45.5.454 1:STN:280:DyaK383otl2rsA%3D%3D
28. J Jaehne C Urmacher HT Thaler, et al. 1992 Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma J Cancer Res Clin Oncol 118 6 474 479 1352299 10.1007/BF01629433 1:STN:280:DyaK38zhslWntQ%3D%3D
29. XL Zhang YS Yang DP Xu, et al. 2009 Comparative study on overexpression of HER2/neu and HER3 in gastric cancer World J Surg 10 33 2112 2118 10.1007/s00268-009-0142-z
30. GZ Yu Y Chen JJ Wang 2009 Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance J Cancer Res Clin Oncol 135 10 1331 1339 19337752 10.1007/s00432-009-0574-8 1:CAS:528:DC%2BD1MXhtVSit7fF
31. KE Lee HJ Lee YH Kim, et al. 2003 Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer Jpn J Clin Oncol 33 173 179 12810831 10.1093/jjco/hyg039 (Pubitemid 43102860)
32. AH Marx L Tharun J Muth, et al. 2009 HER-2 amplification is highly homogenous in gastric cancer Hum Pathol 40 6 769 777 19269014 10.1016/j.humpath.2008.11.014 1:CAS:528:DC%2BD1MXmtFektb8%3D
33. D Yu MC Hung 2000 Overexpression of ErbB2 in cancer and ErbB2-targeting strategies Oncogene 11 6115 6121 10.1038/sj.onc.1203972 (Pubitemid 32059461)